¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"corticotropin zinc hydroxide injectable suspension"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hydroxide
    ¼ö»êÈ­¹°
  • corticotropin
    ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó, ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ
  • corticotropin-releasing factor
    ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ
  • corticotropin-releasing hormone
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇɺкñÈ£¸£¸ó
  • protoporphyrin zinc
    ¾Æ¿¬ÇÁ·ÎÅäÆ÷¸£ÇǸ°
  • zinc
    ¾Æ¿¬
  • zinc alloy
    ¾Æ¿¬ÇÕ±Ý
  • zinc colic
    ¾Æ¿¬±ÞÅëÁõ
  • zinc ointment
    ¾Æ¿¬¿¬°í
  • zinc oxide ointment
    »êÈ­¾Æ¿¬¿¬°í
  • zinc sulfate
    ¾Æ¿¬È²»ê¿°
  • zinc sulfate flotation
    Ȳ»ê¾Æ¿¬ºÎÀ¯¹ý
  • aqueous suspension
    ¼ö¼ººÎÀ¯¾×
  • brow suspension
    ´«½ç°É±â
  • liquid suspension
    ¾×üºÎÀ¯¾×
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hydroxide
    ¼ö»êÈ­¹°
  • suspension
    1.ºÎÀ¯¾×, 2.°É±â
  • protoporphyrin zinc
    ¾Æ¿¬ÇÁ·ÎÅäÆ÷¸£ÇǸ°
  • zinc
    ¾Æ¿¬
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hydroxide
    ¼ö»êÈ­¹°
  • corticotropin
    ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ð´À ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ
  • corticotropin releasing factor
    ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ
  • corticotropin-releasing hormone
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇɺкñÈ£¸£¸ó
  • zinc alloy
    ¾Æ¿¬ÇÕ±Ý
  • zinc colic
    ¾Æ¿¬±ÞÅëÁõ
  • zinc sulfate flotation
    Ȳ»ê¾Æ¿¬ºÎÀ¯
  • zinc ointment
    ¾Æ¿¬¿¬°í
  • zinc oxide ointment
    »êÈ­¾Æ¿¬¿¬°í
  • zinc sulfate
    Ȳ»ê¾Æ¿¬
  • zinc
    ¾Æ¿¬
  • aqueous suspension
    ¼ö¼ººÎÀ¯¾×
  • brow suspension
    ´«½ç°É±â
  • craniofacial suspension
    ¸Ó¸®¾ó±¼¸Å´Þ±â, µÎ°³¾È¸éÇö¼ö
  • suspension culture
    Çöʹè¾ç, ºÎÀ¯¹è¾ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ammonium hydroxide
    ¼ö»êÈ­¾Ï¸ð´½
  • aqueous suspension
    ¼ö¼ºÇöʾ×(â©àõúãöúäû)
  • injectable powder
    ÁÖ»çºÐ¸»Á¦.
  • injectable powder
    ºÐ¸»ÁÖ»çÁ¦.
  • protamin(e) zinc insulin
    ÇÁ·ÎŸ¹Î¾Æ¿¬ Àν¶¸°.
  • protamin(e) zinc insulin
    ÇÁ·ÎŸ¹Î¾Æ¿¬ Àν¶¸°.
  • CRH (corticotropin releasing hormone)
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ ºÐºñÈ£¸£¸ó
  • Corticotropin
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ
  • Corticotropin releasing hormone
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇɺкñÈ£¸£¸ó
  • adenoma,corticotropin-secreting
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ ºÐºñ¼º(¡­ÝÂÝôàõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • insulin zinc suspension
    Àν¶¸°¾Æ¿¬Çöʾ×.
  • injectable powder
    ºÐ¸»ÁÖ»çÁ¦.
  • injectable powder
    ÁÖ»çºÐ¸»Á¦.
  • adenoma,corticotropin-secreting
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ ºÐºñ¼º(¡­ÝÂÝôàõ)
  • ammonium hydroxide
    ¼ö»êÈ­¾Ï¸ð´½
  • cadmium hydroxide
    ¼ö»êÈ­(â©ß«ûù)Ä«µå¹Ì¿ò.
  • corticotropin
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ.
  • corticotropin-releasing factor =CRF
    ºÎ½ÅÇÇÁú ÀÚ±ØÈ£¸£¸ó ¹æÃâÀÎÀÚ(Üù ãìù«òõô§Ð½¡­Û¯õóì×í­).
  • corticotropin-releasing hormone
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ ºÐºñÈ£¸£¸ó
  • ferric hydroxide
    ¼ö»êÈ­Á¦ÀÌö, ¼ö»êȭö(â©ß«ûùôÑ).
  • sodium hydroxide
    ¼ö»êÈ­³ªÆ®·ý
  • aqueous suspension
    ¼ö¼ºÇöʾ×(â©àõúãöúäû)
  • bladder neck suspension procedure
    ¹æ±¤°æºÎ Çö¼ö ¼ö¹ý
  • culture, suspension
    ºÎÀ¯¹è¾ç
  • laryngoscopy, suspension
    Çö¼öÈĵΰæ°Ë»ç(¹ý)
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • zinc sulfate flotation
    Ȳ»ê¾Æ¿¬ºÎÀ¯¹ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hydroxide ion
    ÇÏÀ̵å·Ï»çÀ̵å ÀÌ¿Â
  • corticotropin
    "ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ, (ÔÒ) adrenocorticotropic hormone"
  • corticotropin releasing hormone
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ À¯¸®(ë´×î) È£¸£¸ó
  • suspension
    ÇöŹ(¾×) (úØöú(äû))
  • suspension culture
    Çöʹè¾ç (úØöúÛÆå×)
  • globin zinc insulin
    ±Û·Îºó ¾Æ¿¬(䬿ç)Àν¶¸°
  • protamine zinc insulin
    ÇÁ·ÎŸ¹Î ¾Æ¿¬(䬿ç) Àν¶¸°
  • zinc finger
    ¾Æ¿¬(䬿ç) ¼Õ°¡¶ô
  • zinc sulfate turbidity test
    Ȳ»ê¾Æ¿¬(üÜ߫䬿ç) ȥʵµ½ÃÇè(ûèöúÓøãËúÐ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • suspension
    Çöʾ×, ºÎÀ¯¾×
  • zinc
    ¾Æ¿¬
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SIS semantic indexing system; serotinin irritation syndrome; simian sarcoma; simulator-induced syndrome;...
KOH Potassium Hydroxide [HP 272-3]
LAH lactalbumin hydrolysate; left anterior hemiblock; left atrial hypertrophy; Licentiate of Apothecarie...
MAFH macroaggregated ferrous hydroxide
pOH hydroxide ion concentration in a solution
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HS Hindlimb suspension
PSIFT Platelet Suspension Immunofluorescence Test
TST Tail Suspension Test
Ca(OH)2 Calcium hydroxide
Alum aluminium hydroxide
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • insulin zinc suspension
    Àν¶¸° ¾Æ¿¬ Çöʾ×
  • injectable powder
    ºÐ¸» ÁÖ»çÁ¦
  • corticotropin-like intermediate lobe peptide

    corticotropin-releasing factor (ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ¿ä¼Ò, ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ÀÎÀÚ

  • corticotropin-secreting adenoma
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ ºÐºñ¼º ¼±Á¾
  • calcium hydroxide
    ¼ö»êÈ­ Ä®½·
    ¹é»ö ºÐ¸»·Î Á¸ÀçÇÏ´Â ¿°. ±¹¼ÒÀûÀÎ ¼ö·ÅÁ¦·Î »ç¿ëµÈ´Ù.
  • potassium hydroxide
    ¼ö½ÅÈ­ Ä®·ý
  • sodium hydroxide
    ¼ö»êÈ­ ³ªÆ®·ý
    ¹é»öÀÇ °íü. ÀÛ°í µÕ±Ù ¸ð¾ç, ¹ÚÆí ¸ð¾ç, ¸·´ë ¸ð¾ç µî ¿©·¯ ¸ð¾çÀ¸·Î Á¸ÀçÇÑ´Ù. °­ÇÑ ¾ËÄ®¸®¼º. Á¦¾×¿¡¼­ ¾ËÄ®¸®È­Á¦·Î »ç¿ëÇÑ´Ù.
  • colloid suspension
    ÄÝ·ÎÀ̵å Çöʾ×
  • nystatin suspension
    ´Ï½ºÅ¸Æ¾ Çöʾ×
    C46H77NO19.
  • suspension cell culture
    ¼¼Æ÷ ÇöŹ ¹è¾ç
  • suspension wire fixation
    Çö¼ö °­¼± °íÁ¤
  • viable cell suspension
    »ý¼¼Æ÷ ºÎÀ¯¾×
  • dietary zinc
    ½ÄÀ̼º ¾Æ¿¬
  • protamin zinc insulin
    ÇÁ·ÎŸ¹Î ¾Æ¿¬
  • zinc
    ¾Æ¿¬
    û¹é»öÀÇ ±Ý¼Ó ¿ø¼Ò·Î ¸¹Àº ¾Æ¿°¿¬ÀÌ ÀǾàǰÀ¸·Î »ç¿ëµÈ´Ù. ¿ø¼Ò±âÈ£ Zn, ¿øÀÚ¹øÈ£ 30 ¿øÀÚ·® 65.37ÀÌ´Ù. ¾Æ¿¬Àº Èí¼öµÇ¸é µ¶¼ºÀ» °®±â ¶§¹®¿¡ ¾Æ¿¬ÀÇ ¸¸¼º Áßµ¶°ú ºñ½ÁÇÏ°Ô µÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
amorphous insulin zinc suspension Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection.
Synonym: amorphous insulin zinc suspension, semilente insulin.
(05 Mar 2000)
crystalline insulin zinc suspension A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours.
Synonym: crystalline insulin zinc suspension.
(05 Mar 2000)
prompt insulin zinc suspension Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection.
Synonym: amorphous insulin zinc suspension, semilente insulin.
(05 Mar 2000)
insulin zinc suspension A sterile buffered suspension with zinc chloride, containing 40 or 80 units per ml; the solid phase of the suspension consists of a mixture of 7 parts of crystalline insulin and 3 parts of amorphous insulin.
Synonym: lente insulin.
(05 Mar 2000)
extended insulin zinc suspension A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours.
Synonym: crystalline insulin zinc suspension.
(05 Mar 2000)
injectable 1. Capable of being injected into anything.
2. Capable of receiving an injection.
(05 Mar 2000)
beta-corticotropin Acid-or pepsin-degraded beta-corticotropin.
Synonym: corticotropin.
(05 Mar 2000)
receptors, corticotropin Cell surface receptors that bind corticotropin (acth, adrenocorticotropic hormone) with high affinity and trigger intracellular changes. Pharmacology suggests there may be multiple acth receptors. An acth receptor has been cloned and belongs to a subfamily of g-protein-coupled receptors. In addition to the adrenal cortex, acth receptors are found in the brain and immune systems.
(12 Dec 1998)
receptors, corticotropin-releasing hormone Cell surface proteins that bind corticotropin-releasing hormone with high affinity and trigger intracellular changes which influence the behaviour of cells. The corticotropin releasing-hormone receptors on anterior pituitary cells mediate the stimulation of corticotropin release by hypothalamic corticotropin releasing factor. The physiological consequence of activating corticotropin-releasing hormone receptors on central neurons is not well understood.
(12 Dec 1998)
corticotropin Adrenocorticotropic hormone (ACTH), a normal by-product of the anterior pituitary gland acts by controlling the secretion of the adrenal hormone, cortisol.
(27 Sep 1997)
corticotropin-like intermediate-lobe peptide <protein> A product of propiomelanocortin with unknown function.
Acronym: CLIP
(05 Mar 2000)
corticotropin-releasing factor <endocrinology, physiology> A neuropeptide released by the hypothalamus that stimulates the release of corticotropin by the anterior pituitary gland.
Chemical name: Corticotropin-releasing factor
Synonym: corticoliberin, corticotropin releasing factor.
(12 Dec 1998)
corticotropin-releasing hormone <endocrinology, physiology> A neuropeptide released by the hypothalamus that stimulates the release of corticotropin by the anterior pituitary gland.
Chemical name: Corticotropin-releasing factor
Synonym: corticoliberin, corticotropin releasing factor.
(12 Dec 1998)
aluminum hydroxide <chemical> Hydrated aluminum. A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc.
Pharmacological action: antacids, pharmaceutic aid.
Chemical name: Aluminum hydroxide (Al(OH)3)
(12 Dec 1998)
aluminum hydroxide gel A suspension containing Al2O3, mainly in the form of aluminum hydroxide, used as an antacid; a dried form, with the same use, is obtained by drying the product of interaction in aqueous solution of an aluminum salt with ammonium or sodium carbonate.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • corticotropin
    -phin()ºÎ½ÅÇÇÁúÀÚ±Ø È£¸£¸ó 9
  • injectable
    (¾à¹°ÀÌ)Áֻ簡´ÉÇÑ;Áֻ簡´É¹°Áú
  • suspension
    ¸Å´Þ±â; ºÎÇ¥; ¹Ì°á; Á¤ÇÐ; ÁßÁö
  • suspension
    ¸Å´à;¸Å´Þ¸²;¸Å´Ù´Â ÁöÁÖ;(Ư±ÇÀÇ)ÀϽÃÁ¤Áö;Á¤Á÷;ÁßÁö;ÁöºÒÁ¤Áö;Â÷ü ¹öÆÃÀåÄ¡;ºÎÀ¯(»óÅÂ);Çöʾ×
  • suspension bridge
    Àû±³
  • hydroxide
    ¼ö»êÈ­¹°
  • calcium hydroxide
    ¼ö»êÈ­Ä®½·;¼Ò¼®È¸
  • hydroxide
    ¼ö»êÈ­¹°
  • potassium hydroxide
    ¼ö»êÈ­ Ä®·ý 9
  • sodium hydroxide
    ¼ö»êÈ­ ³ªÆ®·ý 
  • zinc
    ¾Æ¿¬
  • zinc
    ¾Æ¿¬(±Ý¼Ó ¿ø¼Ò,±âÈ£ Zn,¹øÈ£ 39)
  • zinc blende
    ¼¶ ¾È¿¬±¤
  • zinc ointmcnt
    ¾Æ¿¬È­ ¿¬°í
  • zinc oxide
    »êÈ­ ¾Æ¿¬
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á